Literature DB >> 34286320

Exchange transfusion for neonatal hyperbilirubinemia: A multicenter, prospective study of Turkish Neonatal Society.

Emel Okulu1, Ömer Erdeve1, Oğuz Tuncer2, Sabahattin Ertuğrul3, Hülya Özdemir4, Nukhet Aladağ Çiftdemir5, Ayşegül Zenciroğlu6, Begüm Atasay1.   

Abstract

Objective: The frequency of neonatal exchange transfusion has declined in recent years, but is still performed in many countries. The procedure is associated with complications. The aim of the study was to determine the clinical features and etiologies of infants with hyperbilirubinemia who underwent exchange transfusion and evaluate the adverse events and clinical outcomes. Material and
Methods: We performed a secondary analysis of the multicenter Turkish Neonatal Jaundice Online Registry data. Otherwise healthy newborns born ≥35 weeks of gestation who were hospitalized for jaundice and underwent exchange transfusion were included.
Results: One-hundred thirty-two patients with a mean serum bilirubin level on admission of 24.9±9.1 mg/dL were enrolled in the study. The most common cause for exchange transfusion was hemolytic jaundice (63.6%), followed by lack of proper feeding (12.9%). It was found that the infants with lack of proper feeding were discharged earlier from the maternity ward (p=0.02), but they were admitted to hospital later (p<0.001) with a higher bilirubin level (p=0.001), and geater weight loss (p=0.04). The reported rate of adverse events associated with exchange transfusion was 11.4%. The most common complication was thrombocytopenia (40%). None of the infants died during the procedure. Acute bilirubin encephalopathy was reported in 13 (9.8%) patients.
Conclusion: Severe hyperbilirubinemia requiring exchange transfusion and acute bilirubin encephalopathy are still challenging problems in neonatal periodin our country. The policies including blood group analysis of pregnant women, programs informing parents about breastfeeding and jaundice, and monitoring bilirubin levels of high-risk newborns should be developed to reduce the necessitating for exchange transfusion and to avoid related complications.
Copyright © 2021 Turkish Pediatric Association.

Entities:  

Keywords:  Complication; exchange transfusion; hyperbilirubinemia; newborn

Year:  2021        PMID: 34286320      PMCID: PMC8269941          DOI: 10.14744/TurkPediatriArs.2020.65983

Source DB:  PubMed          Journal:  Turk Arch Pediatr        ISSN: 2757-6256


  35 in total

1.  Transfusion guidelines for neonates and older children.

Authors:  Brenda E S Gibson; Audrey Todd; Irene Roberts; Derwood Pamphilon; Charles Rodeck; Paula Bolton-Maggs; Geoff Burbin; J Duguid; F Boulton; H Cohen; N Smith; D B L McClelland; M Rowley; G Turner
Journal:  Br J Haematol       Date:  2004-02       Impact factor: 6.998

Review 2.  Hyperbilirubinemia and kernicterus.

Authors:  Steven M Shapiro; Vinod K Bhutani; Lois Johnson
Journal:  Clin Perinatol       Date:  2006-06       Impact factor: 3.430

Review 3.  Problems associated with early discharge of newborn infants. Early discharge of newborns and mothers: a critical review of the literature.

Authors:  P Braveman; S Egerter; M Pearl; K Marchi; C Miller
Journal:  Pediatrics       Date:  1995-10       Impact factor: 7.124

4.  Exchange transfusion for neonatal hyperbilirubinemia: an 8-year single center experience at a tertiary neonatal intensive care unit in Turkey.

Authors:  Nilay Hakan; Aysegul Zenciroglu; Mustafa Aydin; Nurullah Okumus; Arzu Dursun; Dilek Dilli
Journal:  J Matern Fetal Neonatal Med       Date:  2014-09-22

5.  Clinical report from the pilot USA Kernicterus Registry (1992 to 2004).

Authors:  L Johnson; V K Bhutani; K Karp; E M Sivieri; S M Shapiro
Journal:  J Perinatol       Date:  2009-02       Impact factor: 2.521

6.  Whole blood versus red cells and plasma for exchange transfusion in ABO haemolytic disease.

Authors:  S Yigit; T Gursoy; T Kanra; M Aydin; G Erdem; G Tekinalp; M Yurdakok
Journal:  Transfus Med       Date:  2005-08       Impact factor: 2.019

7.  Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.

Authors: 
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

Review 8.  [High-dose intravenous immunoglobulin therapy and neonatal jaundice due to red blood cell alloimmunization].

Authors:  F Monpoux; C Dageville; A-M Maillotte; S De Smet; F Casagrande; P Boutté
Journal:  Arch Pediatr       Date:  2009-07-07       Impact factor: 1.180

9.  Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns.

Authors:  V K Bhutani; L Johnson; E M Sivieri
Journal:  Pediatrics       Date:  1999-01       Impact factor: 7.124

Review 10.  Necrotizing enterocolitis: treatment based on staging criteria.

Authors:  M C Walsh; R M Kliegman
Journal:  Pediatr Clin North Am       Date:  1986-02       Impact factor: 3.278

View more
  1 in total

Review 1.  Exchange Transfusion in Neonatal Sepsis: A Narrative Literature Review of Pros and Cons.

Authors:  Shigeo Iijima
Journal:  J Clin Med       Date:  2022-02-24       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.